| Alzheimer |
| Brain diseases |
| Research |
| Tau |
| APP |
| Abeta |
| VCDN group |
 |
| ALS/PDC Guam |
| AGD |
| Bri |
| CBD |
|
DLDH |
| DM1 |
| Down S |
| GSS |
| FTD |
| FTDP-17 |
| Huntington |
| Hallenvorden |
| IBM |
| Lewy BD |
| MSA |
| NPiD c |
| Parkinson D Guadeloupe |
| Parkinson |
| Dementia in Parkinson |
| Pick |
| Prion |
| PSP |
| PEP |
| Semantic D |
|
SSP |
| ToD |
| APP metabolism and function |
| Primary structure, sequence and functional regions |
| Cartoon on the structure |
| APP splicing |
| Mutations |
| Cascade hypothesis |
| APP & cholinergy |
| Links between APP and neurodegeneration |
| Abeta map |
| APP Carboxy terminal fragments, a and b stubs |
| Cleavage of APP, production of APP-CTFs and Abeta |
| alpha secretase cleavage |
| beta secretase (BACE, ...) |
| gamma secretase and PS1 |
| sa-APP,a possible neuroprotectant |
| RIP: regulated intramembrane proteolysis |
| APP- Tau interaction |
| Other molecular aspects |
| Alzheimer |
 |
| Research |
| Tau |
| APP |
| Ab |
| ApoE |
| catenin |
| NSE |
| Parkin |
| Pin1 |
| Presenilins, |
| Proteasome |
| Synuclein |
| Ubiquitin |
